Items where Author is "Nazari, J."
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.
Article
(2024) Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a multicenter, phase III, randomized, double-blind, equivalency clinical trial. Frontiers in Immunology. p. 10. ISSN 1664-3224
(2022) National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. SCIENTIFIC REPORTS. ISSN 20452322 (ISSN)
(2022) National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019. Scientific Reports. ISSN 20452322 (ISSN)